Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313415025> ?p ?o ?g. }
- W4313415025 endingPage "50" @default.
- W4313415025 startingPage "50" @default.
- W4313415025 abstract "Background and Objectives: There is no consensus regarding the optimal therapy sequence in stage II and III bladder cancer. The study aimed to evaluate the long-term oncologic outcomes in patients with bladder cancer after a multimodality approach. Materials and methods: Medical files of 231 consecutive patients identified with stage II (46.8%), IIIA (30.3%), and IIIB (22.9%) transitional cell carcinoma of the bladder (BC) treated with a multimodality approach were retrospectively reviewed. The treatment consisted of transurethral resections or cystectomy, radiotherapy alone or concurrent chemoradiotherapy as definitive treatment, or neoadjuvant chemotherapy using platinum salt regimens. Results: Median age at diagnosis was 65 ± 10.98 years. Radical or partial cystectomy was performed in 88 patients (37.1%), and trans-urethral resection of bladder tumor (TURBT) alone was performed in 143 (61.9%) patients. Overall, 40 patients (17.3%) received neoadjuvant chemotherapy and 82 (35.5%) received definitive chemoradiotherapy. After a median follow-up of 30.6 months (range 3-146 months), the median disease-free survival (DFS) for an entire lot of patients was 32 months, and the percentage of patients without recurrence at 12, 24, and 36 months was 86%, 58%, and 45%, respectively. Patients receiving neoadjuvant chemotherapy had a better oncologic outcome compared to patients without neoadjuvant chemotherapy (median DFS not reached vs. 31 months, p = 0.038, HR = 0.55, 95% CI 0.310-0.951). There was a trend for better 3-year DFS with radical cystectomy vs. TURBT (60 months vs. 31 months, p = 0.064). Definitive chemoradiotherapy 3-year DFS was 58% compared to 44% in patients who received radiotherapy or chemotherapy alone. Conclusions: In patients with stages II and III, both neoadjuvant chemotherapy and concurrent radio-chemotherapy are valid options for treatment and must be part of a multidisciplinary approach." @default.
- W4313415025 created "2023-01-06" @default.
- W4313415025 creator A5000505246 @default.
- W4313415025 creator A5003949732 @default.
- W4313415025 creator A5011499877 @default.
- W4313415025 creator A5018962535 @default.
- W4313415025 creator A5027031004 @default.
- W4313415025 creator A5029692581 @default.
- W4313415025 creator A5035127360 @default.
- W4313415025 creator A5051754573 @default.
- W4313415025 creator A5067082991 @default.
- W4313415025 creator A5077554186 @default.
- W4313415025 creator A5087748307 @default.
- W4313415025 date "2022-12-27" @default.
- W4313415025 modified "2023-10-18" @default.
- W4313415025 title "Long-Term Outcome of Patients with Stage II and III Muscle-Invasive Urothelial Bladder Cancer after Multimodality Approach. Which Is the Best Option?" @default.
- W4313415025 cites W1855374361 @default.
- W4313415025 cites W1867318780 @default.
- W4313415025 cites W1893740135 @default.
- W4313415025 cites W1941332786 @default.
- W4313415025 cites W1968487988 @default.
- W4313415025 cites W1975918912 @default.
- W4313415025 cites W1988855705 @default.
- W4313415025 cites W1989605682 @default.
- W4313415025 cites W2008523684 @default.
- W4313415025 cites W2010464208 @default.
- W4313415025 cites W2029132015 @default.
- W4313415025 cites W2039310245 @default.
- W4313415025 cites W2051762085 @default.
- W4313415025 cites W2065741451 @default.
- W4313415025 cites W2101562875 @default.
- W4313415025 cites W2102297555 @default.
- W4313415025 cites W2103257412 @default.
- W4313415025 cites W2103818040 @default.
- W4313415025 cites W2108496206 @default.
- W4313415025 cites W2113156769 @default.
- W4313415025 cites W2115592448 @default.
- W4313415025 cites W2129456992 @default.
- W4313415025 cites W2130188603 @default.
- W4313415025 cites W2138629620 @default.
- W4313415025 cites W2147027947 @default.
- W4313415025 cites W2157244703 @default.
- W4313415025 cites W2164389238 @default.
- W4313415025 cites W2164960433 @default.
- W4313415025 cites W2165427711 @default.
- W4313415025 cites W2166453367 @default.
- W4313415025 cites W2170705825 @default.
- W4313415025 cites W2298635363 @default.
- W4313415025 cites W2332342311 @default.
- W4313415025 cites W2443056117 @default.
- W4313415025 cites W2462649057 @default.
- W4313415025 cites W2566236100 @default.
- W4313415025 cites W2737546054 @default.
- W4313415025 cites W2754106539 @default.
- W4313415025 cites W2767805252 @default.
- W4313415025 cites W2781043244 @default.
- W4313415025 cites W2783414919 @default.
- W4313415025 cites W2794092054 @default.
- W4313415025 cites W2807001445 @default.
- W4313415025 cites W2809685212 @default.
- W4313415025 cites W2889646458 @default.
- W4313415025 cites W2892569486 @default.
- W4313415025 cites W2897844118 @default.
- W4313415025 cites W2936221437 @default.
- W4313415025 cites W2992455749 @default.
- W4313415025 cites W3011714452 @default.
- W4313415025 cites W3021314346 @default.
- W4313415025 cites W3032408200 @default.
- W4313415025 cites W3081622691 @default.
- W4313415025 cites W3082065471 @default.
- W4313415025 cites W3166949503 @default.
- W4313415025 cites W3171826947 @default.
- W4313415025 cites W3172811456 @default.
- W4313415025 cites W4200026971 @default.
- W4313415025 cites W4200537709 @default.
- W4313415025 cites W4206793550 @default.
- W4313415025 cites W4211053712 @default.
- W4313415025 cites W4214932218 @default.
- W4313415025 cites W4220743737 @default.
- W4313415025 cites W4282578305 @default.
- W4313415025 doi "https://doi.org/10.3390/medicina59010050" @default.
- W4313415025 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36676675" @default.
- W4313415025 hasPublicationYear "2022" @default.
- W4313415025 type Work @default.
- W4313415025 citedByCount "1" @default.
- W4313415025 countsByYear W43134150252023 @default.
- W4313415025 crossrefType "journal-article" @default.
- W4313415025 hasAuthorship W4313415025A5000505246 @default.
- W4313415025 hasAuthorship W4313415025A5003949732 @default.
- W4313415025 hasAuthorship W4313415025A5011499877 @default.
- W4313415025 hasAuthorship W4313415025A5018962535 @default.
- W4313415025 hasAuthorship W4313415025A5027031004 @default.
- W4313415025 hasAuthorship W4313415025A5029692581 @default.
- W4313415025 hasAuthorship W4313415025A5035127360 @default.
- W4313415025 hasAuthorship W4313415025A5051754573 @default.
- W4313415025 hasAuthorship W4313415025A5067082991 @default.
- W4313415025 hasAuthorship W4313415025A5077554186 @default.
- W4313415025 hasAuthorship W4313415025A5087748307 @default.